Literature DB >> 27363619

CXCR4 signaling in health and disease.

Tommaso Pozzobon1, Giacomo Goldoni2, Antonella Viola1, Barbara Molon3.   

Abstract

Chemokines and chemokine receptors regulate multiple processes such morphogenesis, angiogenesis and immune responses. Among the chemokine receptors, CXCR4 stands out for its pleiotropic roles as well as for its involvement in several pathological conditions, including immune diseases, viral infections and cancer. For these reasons, CXCR4 represents a crucial target in drug development. In this review, we discuss of CXCR4 receptor properties and signaling in health and diseases, focusing on the WHIM syndrome, an inherited immunodeficiency caused by mutations of the CXCR4 gene.
Copyright © 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CXCL12; CXCR4; Chemokine receptors; Immunity; Signaling pathway; WHIM syndrome

Mesh:

Substances:

Year:  2016        PMID: 27363619     DOI: 10.1016/j.imlet.2016.06.006

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  72 in total

1.  A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis.

Authors:  Z Xiang; Z-J Zhou; G-K Xia; X-H Zhang; Z-W Wei; J-T Zhu; J Yu; W Chen; Y He; R E Schwarz; R A Brekken; N Awasthi; C-H Zhang
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

2.  15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.

Authors:  Tyvette S Hilliard; Gabriella Miklossy; Christopher Chock; Peibin Yue; Philip Williams; James Turkson
Journal:  Mol Cancer Ther       Date:  2017-01-09       Impact factor: 6.261

3.  Systems biology analysis of longitudinal functional response of endothelial cells to shear stress.

Authors:  Nassim E Ajami; Shakti Gupta; Mano R Maurya; Phu Nguyen; Julie Yi-Shuan Li; John Y-J Shyy; Zhen Chen; Shu Chien; Shankar Subramaniam
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-26       Impact factor: 11.205

4.  Correction to: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.

Authors:  Alireza Nazari; Hossein Khorramdelazad; Gholamhossein Hassanshahi
Journal:  Int J Clin Oncol       Date:  2018-08       Impact factor: 3.402

Review 5.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  CXCR4 signaling and function require the expression of the IgD-class B-cell antigen receptor.

Authors:  Martin Becker; Elias Hobeika; Hassan Jumaa; Michael Reth; Palash C Maity
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

7.  Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.

Authors:  B Weixler; F Renetseder; I Facile; N Tosti; E Cremonesi; A Tampakis; T Delko; S Eppenberger-Castori; A Tzankov; G Iezzi; C Kettelhack; S D Soysal; U von Holzen; G C Spagnoli; L Terracciano; L Tornillo; Raoul A Droeser; S Däster
Journal:  Cell Oncol (Dordr)       Date:  2017-09-21       Impact factor: 6.730

8.  Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4.

Authors:  Xianlong Gao; You-Hong Cheng; Garrett A Enten; Anthony J DeSantis; Vadim Gaponenko; Matthias Majetschak
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

9.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

10.  RING finger protein 113A regulates C-X-C chemokine receptor type 4 stability and signaling.

Authors:  Travis Lear; Sarah R Dunn; Alison C McKelvey; Aazrin Mir; John Evankovich; Bill B Chen; Yuan Liu
Journal:  Am J Physiol Cell Physiol       Date:  2017-10-04       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.